068270.KS
Celltrion, Inc.
KSC · Healthcare · Biotechnology · KR
KRW 187,100.00
+0.43%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- KRW 1.6K
- Revenue estimate
- KRW 1.46T
Latest reported
- Last report date
- Jul 26, 2026
- EPS actual
- KRW 1.6K
- EPS estimate
- KRW 1.5K
- Revenue actual
- KRW 1.39T
- Revenue estimate
- KRW 1.24T
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +11.9%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026